Table 1.
Base line characteristics of the study population
| Study 1 | Study 2 | Study 3 | Study 4 | Study 5 | Study 6 | |
|---|---|---|---|---|---|---|
|
Year |
2004 |
2006 |
2007 |
2008 |
2010 |
2011 |
|
Study period |
May |
Jun |
May – Nov |
Aug-Oct |
Oct-Dec + Jan 2011 |
Apr-Jun |
|
Patients included (n) |
106 |
50 |
258 |
200 |
33 |
130 |
|
Sex, female patients (%) |
51 |
62 |
54 |
49 |
49 |
50 |
|
Age, months, median (range) |
31 (6–135) |
48 (12–119) |
31 (4–60) |
36 (2–124) |
N.D |
60 (12–120) |
|
Weight, kg, median (range) |
12 (6–33) |
13 (8–30) |
12 (5–21) |
12 (5–33) |
13 (6–29) |
15 (8–32) |
|
Parasites/μL, geometric mean (range) |
21,595 (2,000-160,000) |
36,885 (2,120-200,400) |
43,259 (2,700-192,320) |
17,531 (2,000-192,000) |
18,537 (2,400-185,120) |
10,198 (1,080-112,800) |
| Slide positivity rate, microscopy positive/screened (%) | 175/434 (40%) | 148/277 (53%) | 718/1403 (51%) | 473/745 (63%) | 99/588 (17%) | 599/1002 (60%) |